The Optimised Use of Romozosumab Study
NCT06059222
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
270
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
Romosozumab
DRUG:
Zoledronate
DRUG:
Romosozumab
DRUG:
Zoledronate
DRUG:
Romosozumab
DRUG:
Zoledronate
Sponsor
University of Aarhus